BACKGROUND Measurements of brain volume loss (BVL) in individual patients are currently discussed controversially. One concern is the impact of short-term biological noise, like hydration status. METHODS Three publicly available reliability MRI datasets with scan intervals of days to weeks were used. An additional cohort of 60 early relapsing multiple sclerosis (MS) patients with MRI follow-ups was analyzed to test whether after 1 year pathological BVL is detectable in a relevant fraction of MS patients. BVL was determined using SIENA/FSL. Results deviating from zero in the reliability datasets were considered as within-patient fluctuation (WPF) consisting of the intrinsic measurement error as well as the short-term biological fluctuations...
Comparing baseline and follow-up time point images using SIENA, there was no significant difference ...
Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with dis...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
BACKGROUND Measurements of brain volume loss (BVL) in individual patients are currently discussed co...
Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific processes...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
OBJECTIVE: To describe the dynamics of brain volume loss (BVL) at different stages of relapsing-remi...
Magnetic resonance imaging is an important method to diagnose and evaluate the progression of MS. SI...
Background The added value of brain volume measurements in the clinical practice of multiple scleros...
PURPOSE: We evaluated the intraobserver and interobserver variability in measuring long-term changes...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating and degenerative disorder of the cen...
Comparing baseline and follow-up time point images using SIENA, there was no significant difference ...
Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with dis...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...
BACKGROUND Measurements of brain volume loss (BVL) in individual patients are currently discussed co...
Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific processes...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenera...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
Multiple sclerosis (MS) is a chronic disease with an inflammatory and neurodegenerative pathology. A...
OBJECTIVE: To describe the dynamics of brain volume loss (BVL) at different stages of relapsing-remi...
Magnetic resonance imaging is an important method to diagnose and evaluate the progression of MS. SI...
Background The added value of brain volume measurements in the clinical practice of multiple scleros...
PURPOSE: We evaluated the intraobserver and interobserver variability in measuring long-term changes...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Multiple sclerosis (MS) is a chronic inflammatory demyelinating and degenerative disorder of the cen...
Comparing baseline and follow-up time point images using SIENA, there was no significant difference ...
Purpose: Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with dis...
Background: Volumetric MRI surrogate markers of disease progression are lacking. Objective: To estab...